TickerGuard
Buy Day today: Poor (44) Weak market breadth · no major macro event
PYPD

PolyPid

Healthcare · Biotechnology

6.20$ -1.8% vs. previous close Closing price · As of: Nov 16, 2026

Ownership

Ownership Structure

Who owns PolyPid (PYPD)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 61.2% of the shares are freely tradable; institutional investors hold 34.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 34.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 21.2%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 61.2%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 3.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 20Mio.

Largest Shareholders

Institutions

Institutions PYPD
Name Stake (%) Shares Change (%) Date
AIGH Capital Management, LLC 7.41 1,504,741 -5.6 06/30/2026
Rosalind Advisors, Inc. 1.92 389,455 -34.9 06/30/2026
Dafna Capital Management LLC 1.02 207,900 +0.0 06/30/2026
Morgan Stanley - Brokerage Accounts 0.61 123,136 -30.4 06/30/2026
Renaissance Technologies Corp 0.57 116,619 +527.1 06/30/2026
Marshall Wace Asset Management Ltd 0.57 115,014 +0.0 06/30/2026
ADAR1 Capital Management LLC 0.51 103,950 +0.0 06/30/2026
Symmetry Peak Management LLC 0.50 100,881 +15.7 06/30/2026
J. Goldman & Co LP 0.49 99,183 -33.7 06/30/2026
Jane Street Group LLC 0.41 83,126 +284.1 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 16, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?